Navigation Links
Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
Date:6/11/2008

Data Presented as Poster Presentation at the Associated Professional Sleep

Societies 2008 Annual Meeting

BALTIMORE, June 11 /PRNewswire/ -- Data was presented today at the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS) demonstrating that within 20 minutes of administration, Intermezzo(R), an investigational low-dose, sublingual formulation of zolpidem, delivered overall bioavailability that was significantly greater than that produced by a swallowed Ambien(R) tablet containing a zolpidem dose that was nearly 3 times higher. Despite this higher initial bioavailability, zolpidem blood levels from sublingual 3.5 mg Intermezzo(R) were significantly lower four hours after administration than the levels produced by the 10 mg Ambien(R) dose. Transcept Pharmaceuticals is developing Intermezzo(R) for the treatment of insomnia characterized by middle-of-the-night (MOTN) awakenings with difficulty returning to sleep.

"One significant challenge in trying to help insomnia patients return to sleep after a middle-of-the-night awakening is that the most commonly prescribed bedtime medications are not designed to be taken as needed in the middle of the night without risking significant drowsiness the following day," said Thomas Roth, Ph.D., Chief of Sleep Medicine, Henry Ford Hospital Sleep Disorders and Research Center in Detroit and principal investigator in this study. "The only recourse to date for patients has been either to try to predict what nights they will awaken, or to take sleep medication every night at bedtime. Studies of Intermezzo(R) show promise in offering the first viable, 'use only when needed' option for treating awakenings in the middle of the night when they occur."

Intermezzo(R): Rapid bioavailability despite a lower dose

In the pharmacokinetic comparison study presented at APSS, 36 healthy subjects between the ages of 19 and 64 were randomized to receive either a 3.5 mg. Inte
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
3. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
4. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
7. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
8. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
9. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
10. Bionomics Achieves US$1 Million Milestone Payment from Genmab
11. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... NORWALK, Conn. , Aug. 27, 2014  UBM ... , a leading online community for medical imaging professionals, ... Association for Medical Imaging Management,s 2014 Annual Meeting ... the conference coverage: , 11 Principles ... management can lead to greater profitability. , ...
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- Emergency ... design, blended emergency medical training and response technologies, ... defibrillator) training from the Department of Homeland ... Reserve 81 st Regional Support Command ... contract includes nationwide CPR/AED/First Aid training. The Army ...
(Date:8/27/2014)... , Aug. 27, 2014   Auxilium Pharmaceuticals , Inc. ... biopharmaceutical company, today announced that certain members of the ... Healthcare Conference to be held September 8-10, 2014 in ... , Chief Executive Officer and President, is scheduled to ... portfolio at 10:55 a.m. ET on Wednesday, September 10, ...
Breaking Medicine Technology:Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference 3
... Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in ... it has dosed the first patient with recent onset ... ongoing Phase I study of QPI-1007, the Company,s proprietary ... The Phase I open-label, dose-escalation study was initiated ...
... PHILADELPHIA, Oct. 20 ERT (Nasdaq: ... for the third quarter 2010 on Thursday, November 4, 2010, ... host a conference call at 5:00 PM EDT that day. ... dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 ...
Cached Medicine Technology:Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007 2Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007 3ERT to Announce Third Quarter 2010 Results on November 4, 2010 2
(Date:8/27/2014)... For nearly two decades, audiences around the world ... Deva Premal & Miten with their rapturous Nepali flute ... album in May, their 2014 MANTRAS FOR LIFE TOUR ... globe, including Russia, Ukraine, Israel, Australia, the U.S., Canada, ... new album and a new five-piece band, the love ...
(Date:8/27/2014)... positive hospital blood culture samples are discarded every day ... skin germs instead of specific disease-causing bacteria. , ... clinicians may be able to use the resistance profiles ... patients with antibiotics appropriate to their ailment, Tel Aviv ... Alon of TAU,s Sackler Faculty of Medicine and the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 According ... Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, ... Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, ... 2020," the global ablation technologies market was valued ... estimated to reach a market worth USD 10,611 ...
(Date:8/27/2014)... NH 8/27/14)Dartmouth cancer researchers developed and tested an ... environmental interactions that contribute to disease as published ... , The approach fills a gap in current ... complex interactions among genetic and environmental factors. When ... interactions versus those that reflect chance combinations among ...
(Date:8/27/2014)... 2014 Nava Beauty Store and Spa aims ... patrons from those seeking luxury care products to the everyday ... high end luxurious brands like Valmont and Elemis to cater ... brands like Dermalogica and Bliss to provide easy to use ... also offer purely organic skin care products such as Jurlique, ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:'Junk' blood tests may offer life-saving information 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2
... in the United States who undergo surgery to have ... a recent study shows that men who have their ... cancer returns . ,Researchers studied more than 500 ... study first had a radical prostatectomy and also underwent ...
... is the most common bacterial illness in children and ... of children may be getting treated unnecessarily with antibiotics ... they don’t need them may build up antibiotic resistance, ... a more serious infection. ,According to the new ...
... that certain hormones in the body may yield a ... events and death in people with no symptoms. Researchers ... the current standards used to diagnose heart failure. ... the participants’ blood looking for specific substances and compared ...
... their risk of birth defects. Now, new research shows ... say about 31,000 stroke-related deaths and about 17,000 heart ... fortification was implemented. ,Folic acid lowers homocysteine levels. ... risk for stroke and heart disease. Specialists from the ...
... new study shows the use of antibacterial products, such ... reduce the risk of infectious// disease symptoms in the ... households in New York with at least one preschool-age ... household cleaning and personal hygiene products that contained antibacterial ...
... study suggests drinking extra fluids may do more harm ... ,Researchers examined results from previous studies to determine if ... safe. Previous data has shown during a respiratory infection, ... large amounts of a specific hormone that conserves water. ...
Cached Medicine News:
... High Throughput Screening (UHTS), Analyst GT ... Allows for smooth transfer of assays ... sharing all the detection modalities of ... fluorescence polarization, time-resolved fluorescence, luminescence, absorbance, ...
... Ultra High Throughput Screening (UHTS), Analyst ... performance. Allows for smooth transfer of ... by sharing all the detection modalities ... intensity, fluorescence polarization, time-resolved fluorescence, luminescence, ...
... exclusively for cell-based assays, the NOVOstar provides ... to the flexibility of an on-board reagent ... plate to plate or from three reagent ... the unit has two injectors that can ...
... cDNA and Oligonucleotides The Tecan GENios ... variety applications that are quantified by Fluorescence, Absorbance ... assays in Microplate formats from 6 to ... Cuvettes Independent whether you have to quantitate ...
Medicine Products: